ºÚÁϳԹÏ

  • Compare Products
Menu
Account
Make more informed purchasing decisions with our new product availability and delivery estimate feature, now available on all product pages, in your cart, and during checkout.

News

Learn about key ºÚÁÏ³Ô¹Ï news by reading press releases, as well as mentions of us by external media outlets.
Set Ascending Direction
Page

Items 37 to 48 of 84 total

  1. Trial Drug Can Significantly Block Early Stages of COVID-19 in Engineered Human Tissues
    Trial Drug Can Significantly Block Early Stages of COVID-19 in Engineered Human Tissues
    04/02/2020
  2. IT Service Desks Rush to Support Remote Work Amid Pandemic
    IT Service Desks Rush to Support Remote Work Amid Pandemic
    04/02/2020
  3. Global Biotechnology Firm ºÚÁÏ³Ô¹Ï Launches COVID-19 Staff Safety App
    Global Biotechnology Firm ºÚÁÏ³Ô¹Ï Launches COVID-19 Staff Safety App
    03/31/2020
  4. Curiox Biosystems and ºÚÁÏ³Ô¹Ï Technologies Announce Method to Safely Prepare COVID-19 Blood Samples for Vaccine Research
    Curiox Biosystems and ºÚÁÏ³Ô¹Ï Announce Method to Safely Prepare COVID-19 Blood Samples for Vaccine Research
    03/30/2020
  5. Canadian Biotechnology Company ºÚÁÏ³Ô¹Ï Technologies Provides Critical Support to Sequence the COVID-19 Virus
    Canadian Biotechnology Company ºÚÁÏ³Ô¹Ï Provides Critical Support to Sequence the COVID-19 Virus, Accelerating Vaccine Development
    03/25/2020
  6. VUMC Researchers Developing Potential Coronavirus Antibody Therapies
    VUMC Researchers Developing Potential Coronavirus Antibody Therapies
    03/23/2020
  7. LSI researchers funded in CIHR’s COVID-19 Rapid Research competition
    LSI Researchers Funded in CIHR’s COVID-19 Rapid Research Competition
    03/23/2020
  8. The 21st Annual ºÚÁÏ³Ô¹Ï Science Fair Fun Run Registration is Now Open!
    The 21st Annual ºÚÁÏ³Ô¹Ï Science Fair Fun Run Registration is Now Open!
    09/13/2019
  9. NGen Funding to Transform Manufacturing of Critical Materials in Gene Therapies
    NGen Funding to Transform Manufacturing of Critical Materials in Gene Therapies
    08/21/2019
  10. ºÚÁÏ³Ô¹Ï Technologies Wins Deloitte Best Managed Companies Award
    ºÚÁÏ³Ô¹Ï Wins Deloitte Best Managed Companies Award
    03/07/2019
  11. ºÚÁÏ³Ô¹Ï Technologies Launches mTeSR™ Plus
    ºÚÁÏ³Ô¹Ï Launches mTeSRâ„¢ Plus, a Next-Generation Culture System for Human ES and iPS Cell Maintenance
    01/23/2019
  12. ºÚÁÏ³Ô¹Ï Submits Drug Master File for mTeSR™1, the Most Widely Published Cell Culture Medium for Human Pluripotent Stem Cells
    ºÚÁÏ³Ô¹Ï Submits Drug Master File for mTeSRâ„¢1, the Most Widely Published Cell Culture Medium for Human Pluripotent Stem Cells
    10/23/2018
Set Ascending Direction
Page

Items 37 to 48 of 84 total

Shop By
Filter Results
Resource Type
  1. News 84 items
Apply
News Type
  1. News Mention 23 items
  2. Press Release 61 items
Apply
Copyright © 2025 by ºÚÁϳԹÏ. All rights reserved.